In-situ proliferation contributes to the accumulation of myeloid cells in the spleen during progressive experimental visceral leishmaniasis

Keyphrases

• Visceral Leishmaniasis 100%
• Spleen 100%
• Myeloid Cells 100%
• In Situ 100%
• Hamster 42%
• Leishmania Donovani 28%
• Monocytes 28%
• Cell Proliferation 28%
• Parasite Burden 28%
• Cellularity 28%
• In Vitro Assay 14%
• Overexpression 14%
• Toll-like Receptor 4 (TLR4) 14%
• Interleukin-4 (IL-4) 14%
• Cell Cycle Progression 14%
• Liver 14%
• Transcriptome 14%
• Interleukin-6 14%
• Stem Cells 14%
• High Risk 14%
• Splenomegaly 14%
• Hamster Model 14%
• Cell Division 14%
• Gene Signature 14%
• Oncogene 14%
• Chemical Inhibitors 14%
• Intracellular Infection 14%
• Hematopoiesis 14%
• Mortality Risk 14%
• AKT1 14%
• STAT3 Inhibitor 14%
• Viscera 14%
• In Silico 14%
• Splenic Cells 14%
• BrdU Incorporation 14%
• Replicative Capacity 14%
• CSF2 14%
• In Silico Prediction 14%
• Tumoral Cells 14%
• RTK Signaling 14%
• Myeloid Proliferation 14%

Medicine and Dentistry

• Myeloid Cell 100%
• Experimental Visceral Leishmaniasis 100%
• Visceral Leishmaniasis 42%
• Cell Proliferation 28%
• Ex Vivo 28%
• In Silico 28%
• Parasite Load 28%
• In Vitro 14%
• Infection 14%
• Mitogen-Activated Protein Kinase 14%
• Transcriptome 14%
• Interleukin 4 14%
• Division 14%
• Toll Like Receptor 4 14%
• Gene Expression Profiling 14%
• Cell Division 14%
• Hematopoiesis 14%
• Stem Cell 14%
• Interleukin 6 14%
• Cell Cycle Progression 14%
• Splenomegaly 14%
• Viscera 14%
• Bromodeoxyuridine 14%
• Proto Oncogene 14%
• Leishmania donovani 14%

Immunology and Microbiology

• Visceral Leishmaniasis 100%
• Myeloid 100%
• STAT3 62%
• Cell Proliferation 25%
• Parasite Load 25%
• TLR4 12%
• Transcriptome 12%
• Interleukin 4 12%
• Stem Cell 12%
• Hamster Model 12%
• Interleukin 6 12%
• Cell Division 12%
• Leishmania donovani 12%
• Hematopoiesis 12%
• Splenocyte 12%
• Cell Cycle Progression 12%
• Proto Oncogene 12%
• Gene Expression Assay 12%